XPack MSCV-XP-GFP-EF1-Puro Expression Lentivector

XPack efficiently packages GFP into exosomes which can be used to deliver GFP to target cells

Part 1: Packaging GFP into exosomes with XPack

The XPack-GFP fusion protein is efficiently packaged as exosome cargo and delivered to target cells. HEK-293 cells were transfected with a plasmid encoding an N-terminal XPack-GFP fusion protein (Cat.# XPAK530PA-1). Twenty-four hours later, GFP localization patterns were visualized on a Leica DMI300B fluorescent microscope (Figure 1, upper panel). GFP expression patterns within transfected cells demonstrate a localization pattern characteristic of exosomal loading, with punctate spots along the cell periphery indicating budding vesicles and a brightly fluorescent spot in the cell interior corresponding to the multivesicular body (MVB), the site of exosome assembly and maturation prior to secretion.

After 48 hours, exosomes were isolated using ExoQuick-TC^® and analyzed for GFP via Western blot (Figure 1, lower panel). Equal amounts of exosomal lysates (15 µg) were separated on gradient SDS PAGE gels and detected for GFP protein expression. The control for exosome loading was an anti-CETP antibody. XPack-GFP exosomes had very high amounts of GFP protein loaded as cargo.

Figure 1. XPack efficiently packages GFP into exosomes. (Upper panel) XPack-GFP localization during packaging. (Lower panel) Western blot showing robust loading of GFP into the isolated exosomes.

Part 2: XPack-GFP Exosome Delivery to Target Cells

The XPack-GFP exosomes isolated as described above were then added to recipient HEK-293 cells to test for GFP delivery. Cells exposed to XPack-GFP exosomes were imaged by fluorescent microscopy, which showed subcellular GFP localization consistent with endocytosis of the XPack-GFP exosomes and delivery of the XPack-GFP protein cargo into the cell (Figure 2, left panels). Subsequently, these recipient cells were washed twice with PBS and cellular lysates were prepared for Western blot analysis using anti-GFP antibodies. Anti-GAPDH was used as a cellular protein loading control. The Western blot data further verified the successful delivery of GFP proteins to recipient cells via the XPack exosome engineering technology (Figure 2, right panel).